Dietary flavonoid intake and weight maintenance: three prospective cohorts of 124,086 US men and women followed for up to 24 years by Bertoia, Monica L. et al.
the bmj | BMJ 2016;352:i17 | doi: 10.1136/bmj.i17
RESEARCH
1
open access
1Department of Nutrition, 
Harvard T.H. Chan School of 
Public Health, 655 Huntington 
Avenue, Boston, MA 02115, 
USA
2Channing Division of Network 
Medicine, Brigham and 
Women’s Hospital and Harvard 
Medical School, Boston
3Department of Epidemiology, 
Harvard T.H. Chan School of 
Public Health, Boston
4Department of Medicine, Beth 
Israel Deaconess Medical 
Center, Boston
5Department of Nutrition, 
Norwich Medical School, 
University of East Anglia, 
Norwich, UK
Correspondence to: M L 
Bertoia mbertoia@hsph.
harvard.edu
Additional material is published 
online only. To view please visit 
the journal online (http://dx.doi.
org/10.1136/bmj.i17)
Cite this as: BMJ 2016;352:i17
http://dx.doi.org/10.1136/bmj.i17
Accepted: 11 December 2015
Dietary flavonoid intake and weight maintenance: three 
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for up to 24 years
Monica L Bertoia,1,2 Eric B Rimm,1,2,3 Kenneth J Mukamal,1,4 Frank B Hu,1,2,3 Walter C Willett,1,2,3 
Aedín Cassidy5 
ABSTRACT
ObjeCtive
To examine whether dietary intake of specific flavonoid 
subclasses (including flavonols, flavones, flavanones, 
flavan-3-ols, anthocyanins, and flavonoid polymers) is 
associated with weight change over time.
Design
Three prospective cohort studies.
setting
Health professionals in the United States.
PartiCiPants
124 086 men and women participating in the Health 
Professionals Follow-up Study (HPFS), Nurses’ Health 
Study (NHS), and Nurses’ Health Study II (NHS II).
Main OutCOMe Measure
Self reported change in weight over multiple four year 
time intervals between 1986 and 2011.
results
Increased consumption of most flavonoid subclasses, 
including flavonols, flavan-3-ols, anthocyanins, and 
flavonoid polymers, was inversely associated with 
weight change over four year time intervals, after 
adjustment for simultaneous changes in other lifestyle 
factors including other aspects of diet, smoking status, 
and physical activity. In the pooled results, the 
greatest magnitude of association was observed for 
anthocyanins (−0.23 (95% confidence interval −0.30 
to −0.15) lbs per additional standard deviation/day, 10 
mg), flavonoid polymers (−0.18 (−0.28 to −0.08) lbs 
per additional SD/day, 138 mg), and flavonols (−0.16 
(−0.26 to −0.06) lbs per additional SD/day, 7 mg). 
After additional adjustment for fiber intake, 
associations remained significant for anthocyanins, 
proanthocyanidins, and total flavonoid polymers but 
were attenuated and no longer statistically significant 
for other subclasses.
COnClusiOns
Higher intake of foods rich in flavonols, flavan-3-ols, 
anthocyanins, and flavonoid polymers may contribute 
to weight maintenance in adulthood and may help to 
refine dietary recommendations for the prevention of 
obesity and its potential consequences.
Introduction
Flavonoids are naturally occurring bioactive com-
pounds that represent a constituent of fruits and vege-
tables, beyond calorie and macronutrient content, that 
could potentially influence body weight. In a previous 
food based analysis, we found wide ranging associa-
tions between intake of specific fruits and vegetables 
and weight maintenance.1 Among fruits, an increased 
intake of blueberries, apples, pears, prunes, strawber-
ries, and grapes was inversely associated with weight 
gain. Increased intake of peppers and celery was also 
associated with less weight gain. The mechanisms 
responsible for these benefits and the specific constitu-
ents of these fruits and vegetables that may explain 
these associations are unclear.
The particular fruits and vegetables associated with 
less weight gain are rich sources of several flavonoid 
subclasses, particularly flavonols, anthocyanins, and 
flavones. Animal models and short term human studies 
provide evidence for underlying mechanisms that 
relate flavonoids to weight: several flavonoid subclasses 
have been shown to decrease energy intake,2-5  increase 
glucose uptake in muscle in vivo,6  and decrease glu-
cose uptake in adipose tissue in vitro.6 7  Other studies, 
predominantly focusing on green tea, a rich source of 
the flavan-3-ol subclass of flavonoids, provide evidence 
to suggest that flavonoids may decrease fat absorp-
tion,8 9  increase energy expenditure,9-12  and inhibit adi-
pogenesis.5 13-15
Most weight loss studies to date have focused on the 
flavan-3-ol subclass found in green tea and are limited 
to small numbers of overweight and obese participants. 
Here, we examine, to our knowledge for the first time, 
the associations between habitual consumption of all 
flavonoid subclasses and weight gain among 124 086 
American men and women followed for up to 24 years. 
The results from this analysis may help to refine previ-
ous dietary recommendations and provide people with 
better guidance on which fruits and vegetables to 
choose for the prevention of weight gain. Most adults 
gain weight as they age, and even small increases in 
weight can have a substantial effect on the risk of 
WhAT IS AlReAdy knoWn on ThIS TopIC
Flavonoids are naturally occurring bioactive compounds that represent a 
constituent of fruits and vegetables, beyond calorie and macronutrient content, 
that could potentially influence body weight
Most weight loss studies to date have focused on the flavan-3-ol subclass found in 
green tea and are limited to small numbers of overweight and obese participants
WhAT ThIS STudy AddS
Increased consumption of most flavonoid subclasses was associated with less 
weight gain
The greatest magnitude of association was observed for anthocyanins, flavonoid 
polymers, and flavonols
Choosing high flavonoid fruits and vegetables, such as apples, pears, berries, and 
peppers, may help with weight control.
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hypertension,16  diabetes,17  cardiovascular disease,18 19 
cancer,20  and mortality.21 Strategies to help people to 
maintain a healthy weight from childhood onward are 
therefore critically needed.
Methods
study populations
We used three large prospective cohorts of American 
men and women from 50 states for this analysis. The 
Health Professionals Follow-up Study (HPFS) began in 
1986 and enrolled 51 529 male health professionals aged 
40-75 years.22  The Nurses’ Health Study (NHS) began in 
1976 and enrolled 121 701 female nurses aged 30-55 
years.23  The Nurses’ Health Study 2 (NHS II) began in 
1989 and enrolled 116 686 younger female nurses aged 
25-42 years.24
We excluded men and women with a history of 
chronic disease at baseline because of potential disease 
related weight loss. We considered the following to be 
chronic diseases: obesity (body mass index ≥30), diabe-
tes, cancer, cardiovascular disease, renal disease, pul-
monary disease, liver disease, ulcerative colitis, lupus, 
tuberculosis, multiple sclerosis, amyotrophic lateral 
sclerosis, and Parkinson’s disease. With the exception 
of obesity and cardiovascular disease, we censored peo-
ple who developed these conditions during follow-up 
six years before the date of diagnosis. We censored peo-
ple who developed cardiovascular disease during fol-
low-up at the date of diagnosis. We did not censor 
people if they became obese during follow-up.
We temporarily excluded women who were pregnant 
or lactating for one four year interval and censored peo-
ple who reported gastric bypass surgery. We excluded 
people over age 65 at baseline and censored the remain-
ing people when they reached age 65 owing to potential 
age related sarcopenia. Finally, we excluded men and 
women with missing baseline lifestyle data or who 
reported implausible energy intake (men <800 or >4200 
daily calories; women <600 or >3500 daily calories). 
Our final analysis included 20 525 men from the HPFS, 
39 423 women from the NHS, and 64 138 women from 
the NHS II (see supplemental table A for specific exclu-
sions and supplemental table B for a comparison of 
original versus analysis cohorts).
Patient involvement
No patients were involved in setting the research ques-
tion or the outcome measures, nor were they involved in 
the design and implementation of the study. There are 
no plans to involve patients in the dissemination of the 
results.
assessment of weight
All participants self reported their weight in pounds via 
a questionnaire every two years. We calculated weight 
change within each four year period as the difference in 
weight between the beginning and end of each period, 
so negative differences indicate weight loss and positive 
differences indicate weight gain. There were a total of 
six four year periods in the HPFS and NHS (24 years of 
follow-up) and five in the NHS II (20 years of follow-up). 
Pearson correlation coefficients between self reported 
weight and technician measured weight were 0.97 
among a sample of 140 women in the NHS and 123 men 
in the HPFS.25 We use a conversion factor of 0.454 to 
convert pounds to kg in the text.
assessment of flavonoid intakes
All participants self reported their diet every four years 
using a validated,26  semiquantitative food frequency 
questionnaire. We used the US Department of Agricul-
ture (USDA) flavonoid content of foods and proantho-
cyanidin databases to create a database of the 
flavonoid content per serving of foods and beverages 
included on the study food frequency question-
naire.27 28  We calculated a person’s flavonoid intake as 
the frequency of consumption of specified portions of 
flavonoid containing foods multiplied by the flavonoid 
content (aglycone equivalents) per serving of that food, 
summed across all foods and beverages, as described 
previously.29
We derived intakes of seven flavonoid subclasses—
flavanones (eriodictyol, hesperetin, and naringenin), 
anthocyanins (cyanidin, delphinidin, malvidin, pelar-
gonidin, petunidin, and peonidin), flavan-3-ols (cate-
chin, gallocatechin, epicatechin, epigallocatechin, 
epicatechin 3-gallate, and epigallocatechin 3-gallate), 
proanthocyanidins (dimers, trimers, 4-6mers, 7-10mers, 
and polymers), flavonoid polymers (proanthocyani-
dins, theaflavins, and thearubigins), flavonols (querce-
tin, kaempferol, myricetin, and isorhamnetin), and 
flavones (luteolin and apigenin)—as well as total flavo-
noids (all subclasses summed). As a sensitivity analy-
sis, we additionally examined flavonoid polymers 
excluding thearubigins because current quantification 
methods are somewhat crude. We did not include isofla-
vones in our analysis because levels are very low (<3 
mg/d) in the habitual US diet and, from the extensive 
intervention studies, we know that an isoflavone intake 
of more than 25 mg/d is needed for any biological/clini-
cal effect.30 31
assessment of covariates
Participants reported their lifestyle habits and any 
recent physician diagnosed diseases via a question-
naire every two years. We included baseline age and 
body mass index for that particular four year period 
as covariates in our main models, as well as change 
in smoking status, physical activity level,32 hours of 
sitting or watching TV, and hours of sleep over the 
same time period and change in intake of the follow-
ing foods/nutrients: fried potatoes, juice, whole 
grains, refined grains, fried foods, nuts, whole fat 
dairy, low fat dairy, sugar sweetened drinks, diet 
drinks, sweets, processed meats, non-processed 
meats, trans fat, alcohol, seafood, and caffeine. 
Because citrus juices are a main source of both fla-
vone and flavanone intake in this population, we 
used non-citrus juice rather than all fruit juice as a 
covariate for analyses of these two flavonoid sub-
classes. In additional models, we further adjusted for 
change in total fiber intake (g/day).
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statistical methods
We used multivariable generalized linear regression 
models to examine the association between change in 
weight (lbs) over four years and change in intake of fla-
vonoid subclasses (standard deviation/day) over the 
same four year time interval, as described in a previous 
publication.33 We used robust variance to account for 
within person repeated measures because each person 
could have contributed up to five time periods, and 
results for all four year time intervals are averaged. We 
examined each flavonoid subclass individually and did 
not mutually adjust for other flavonoid subclasses in 
our models. We included all other lifestyle factors 
assessable by questionnaire that we and many others 
have found to be associated with weight change. We did 
not include biological factors (such as blood pressure) 
and drugs because these factors could be mediators (in 
the causal pathway) or direct correlates of mediators of 
the effect of diet on weight change.
We truncated change in intake of flavonoids and 
change in weight at the 0.5th and 99.5th centiles to min-
imize the influence of outliers. The last observation was 
carried forward for missing values of continuous vari-
ables with the exception of diet (main exposure) and 
weight (main outcome), and indicators were used for 
missing values of categorical variables. Missing values 
were carried forward only once for diet and weight, 
after which the follow-up was censored. We did several 
sensitivity analyses, including a complete case analysis 
in which missing values were not carried forward, mod-
els that included obese participants, and models addi-
tionally adjusting for change in total fiber, change in 
total calorie intake, and baseline levels of all covariates.
We pooled results from the three cohorts by using the 
DerSimonian-Laird estimators and the Q statistic to test 
for heterogeneity. The three studies are weighted by the 
inverse of the sum of the study specific variance plus 
the common between studies variance (random effects 
pooling). All analyses used SAS version 9.2 and a two 
tailed α of 0.05.
Results
The average age of participants at baseline ranged from 
36.3 years in women in the NHS II to 46.9 years in men 
in the HPFS and 48.5 years in women in the NHS 
(table 1). Over each four year period, men gained an 
average of 2.2 lbs (1 kg), women in the NHS 2.9 lbs (1.3 
kg), and women in the NHS II 4.4 lbs (2.0 kg). Men had a 
median intake of 224 mg/d of total flavonoids, women in 
the NHS 247 mg/d, and women in the NHS II 236 mg/d. 
Intake of flavonoid polymers was the highest, ranging 
from a median of 118 mg/d to 144 mg/d across the three 
cohorts, and intake of flavones was the lowest, with a 
median of 1.2 to 2.2 mg/d.
table 1 | baseline characteristics and average four year lifestyle changes of men and women in three prospective cohorts
 Characteristics
Health Professionals Follow-up study 
(n=20 525) nurses’ Health study (n=39 423) nurses’ Health study ii (n=64 138)
baseline* (1986) Four year change† baseline* (1986) Four year change† baseline* (1991) Four year change†
Age, years 46.9 (2.9)  – 48.5 (2.4)  – 36.3 (3.4) –
Body mass index, kg/m2 24.6 (1.4)  – 23.6 (1.4) – 22.8 (2.2) –
Weight, lbs 174 (13) 2.2 (−14.0-20.0) 140 (9) 2.9 (−14.0-25.0) 137 (16) 4.4 (−10.0-32.3)
Physical activity, MET-hr/wk 23.5 (19.5) 5.1 (−46.0-100.0) 15.0 (9.9) 1.6 (−34.7-42.6) 21.6 (22.1) 0.4 (−26.1-22.6)
Alcohol, servings/d 0.9 (0.7) 0.0 (−2.1-1.6) 0.5 (0.4) 0.0 (−1.3-0.9) 0.3 (0.4) 0.0 (−0.5-0.8)
Caffeine, mg/d 236 (141) −11 (−372-306) 305 (112) −29 (−354-270) 241 (167) −12 (−280-224)
Flavonols, mg/d 11.7 (7.9-17.0) 2.1 (−14.3-26.9) 12.1 (8.1-18.1) 1.6 (−14.0-27.0) 14.2 (9.3-23.3) 1.3 (−19.5-18.0)
Flavones, mg/d 2.2 (1.2-3.1) 0.1 (−3.4-2.6) 2.1 (1.2-3.1) 0.0 (−2.8-2.2) 1.2 (0.7-2.1) 0.1 (−1.4-2.2)
Flavanones, mg/d 41.7 (16.1-64.9) −0.1 (−79.3-78.9) 37.6 (14.9-63.7) −0.7 (−66.1-62.0) 21.7 (9.3-48.6) −1.3 (−42.5-47.8)
Flavan-3-ols, mg/d 23.9 (13.5-51.0) 0.5 (116.3-115.7) 24.2 (13.2-71.6) −0.9 (−113.6-133.2) 26.1 (13.0-73.6) −0.8 (−119.4-79.4)
Anthocyanins, mg/d 7.7 (3.9-16.2) 2.4 (−24.6-28.7) 11.5 (5.2-19.6) 1.8 (−28.4-28.3) 5.7 (3.1-14.6) 4.5 (−17.5-34.6)
Polymers, mg/d 117.6 (63.4-214.4) 7.1 (−344.7-370.8) 134.9 (72.6-254.4) 1.3 (−342.6-396.5) 143.5 (76.5-267.6) 3.9 (−363.6-252.3)
Total flavonoids, mg/d 223.6 (138.1-362.2) 11.9 (−472.6-531.4) 247.1 (149.8-416.0) 2.5 (−480.3-547.0) 235.9 (136.9-410.6) 8.2 (−506.2-360.3)
Total fruit without juice, servings/d 1.5 (0.7) 0.1 (−1.9-2.1) 1.5 (0.5) 0.0 (−1.9-1.9) 1.2 (0.7) 0.0 (−1.3-1.5)
Total vegetables, servings/d 2.9 (1.0) 0.2 (−2.6-3.7) 3.2 (0.8) 0.1 (−2.6-3.4) 3.1 (1.6) 0.0 (−2.7-3.0)
Whole fat dairy, servings/d 1.0 (0.6) −0.1 (−2.3-1.4) 1.2 (0.5) −0.1 (−2.3-1.2) 0.8 (0.6) 0.0 (−1.4-1.1)
Low fat dairy, servings/d 0.8 (0.6) −0.1 (−2.0-1.7) 0.8 (0.4) 0.1 (−1.5-2.0) 1.1 (0.8) 0.0 (−1.4-1.7)
Seafood, servings/d 0.4 (0.2) 0.0 (−0.5-0.6) 0.3 (0.1) 0.0 (−0.5-0.4) 0.3 (0.2) 0.0 (−0.4-0.3)
Whole grains, servings/d 1.5 (0.8) 0.0 (−2.3-2.9) 0.8 (0.4) 0.1 (−1.6-2.2) 1.3 (0.9) 0.0 (−1.5-1.3)
Refined grains, servings/d 1.2 (0.6) 0.0 (−2.1-2.1) 1.2 (0.4) 0.0 (−1.7-1.7) 1.3 (0.7) −0.1 (−1.3-1.7)
Nuts, servings/d 0.3 (0.3) 0.0 (−0.9-0.8) 0.1 (0.1) 0.0 (−0.6-0.5) 0.1 (0.1) 0.1 (−0.2-0.7)
Sugar sweetened drinks, servings/d 0.3 (0.4) 0.0 (−0.9-0.9) 0.2 (0.2) 0.0 (−0.6-0.7) 0.3 (0.5) 0.0 (−0.9-0.8)
Zero calorie soda, servings/d 0.5 (0.6) 0.0 (−1.5-1.6) 0.5 (0.4) 0.0 (−1.2-1.5) 0.9 (1.1) −0.1 (−1.8-1.5)
Juice, servings/d 0.8 (0.5) 0.0 (−1.6-1.5) 0.7 (0.4) 0.0 (−1.3-1.3) 0.7 (0.6) −0.1 (−1.2-1.0)
Sweets, servings/d 1.3 (0.8) 0.0 (−2.4-2.3) 1.1 (0.5) 0.0 (−1.8-2.2) 1.1 (0.8) −0.1 (−1.5-1.4)
Processed meats, servings/d 0.4 (0.2) 0.0 (−0.8-0.6) 0.3 (0.1) 0.0 (−0.6-0.4) 0.2 (0.2) 0.0 (−0.4-0.4)
Non-processed meats, servings/d 0.6 (0.3) 0.0 (−0.9-0.7) 0.6 (0.2) 0.0 (−0.7-0.6) 0.5 (0.3) 0.0 (−0.5-0.5)
Trans fat, % 1.3 (0.3) 0.0 (−0.7-1.3) 1.7 (0.3) −0.2 (−1.1-0.9) 1.6 (0.5) −0.2 (−1.0-0.5)
*Mean (SD) or median (interquartile range).
†Mean (1st- 99th centile range).
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Increased intake of most flavonoid subclasses, with 
the exception of flavones and flavanones, was inversely 
associated with weight gain (table 2 ). The strongest 
magnitude of association was seen for anthocyanins, 
flavonoid polymers (including proanthocyanidins 
alone), and flavonols; each greater standard deviation 
of daily intake was associated with 0.16 to 0.23 lbs (0.07-
0.10 kg) less weight gained over four year intervals. 
Eighty three per cent of flavanone and 44% of flavone 
intake was derived from citrus fruits and juices. When 
we adjusted intakes of flavones and flavanones for total 
juice intake rather than non-citrus juice, an important 
contributor to weight gain in these cohorts,33  the 
observed associations between intake of these two sub-
classes and weight gain were stronger, inverse, and sta-
tistically significant (table 3, model 4 v model 5).
These associations remained significant for anthocy-
anins and flavonoid polymers (including proanthocy-
anidins alone) when we further adjusted for change in 
total fiber intake but not for flavonols, flavanones, and 
flavan-3-ols. In these models, increased fiber intake was 
inversely associated with weight change in all three 
cohorts. When we excluded thearubigins from total fla-
vonoid polymers, the association with weight change was 
stronger in fully adjusted models: −0.61 (95% confidence 
interval −0.83 to −0.38) lbs per increased SD (76 mg).
Models with and without adjustment for change in 
other aspects of diet were very similar (table 3, model 2 
v model 3). All associations were virtually identical 
when we additionally included change in total energy 
intake as a covariate in our models. In addition, models 
that included obese participants (supplemental table C) 
and models that used a complete case analysis in which 
missing values were not carried forward (supplemental 
table D) showed very similar results.
In these cohorts, the main food sources of anthocya-
nins were blueberries and strawberries, while flavan-3-
ols and their oligomers (polymers) were mainly derived 
from tea and apples. As noted above, orange juice and 
oranges were the main sources of flavanone and flavone 
intakes, and tea and onions were the main sources of 
flavonols in the habitual diet (figure 1). Dietary sources 
of the different flavonoid subclasses were similar across 
cohorts, with the exception of beer providing flavan-3-
ols in the HPFS, peppers providing flavones in the NHS, 
and red wine providing flavones in the NHS II and 
HPFS. The food frequency questionnaire did not 
include all fruits and vegetables, and some known rich 
sources of flavonoids, such as blackberries and raspber-
ries, were not specifically included.
discussion
We found that increased consumption of most flavo-
noid subclasses was associated with less weight gain 
among men and women aged 27-65 followed for up to 24 
years. The greatest magnitude of association was 
observed for anthocyanins, flavonoid polymers, and 
flavonols. These associations remained statistically sig-
nificant for anthocyanins and flavonoid polymers 
(including proanthocyanidins alone) even after further 
adjustment for fiber intake, which was inversely t
ab
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5
 associated with weight change in all three cohorts, indi-
cating that high anthocyanin and flavonoid polymer 
food sources may be associated with less weight gain 
through mechanisms other than fiber content.
The magnitudes of these associations were small, 
less than a pound (<0.5 kg) per increased daily standard 
deviation, but a single serving per day of many fruits 
can often provide more than one standard deviation 
(supplemental table E). For example, one half cup of 
blueberries provides about 121 mg or about 12 standard 
deviations of anthocyanins. Furthermore, losing even 
small amounts of weight can improve health: losing 
just 11-22 lbs (5.0-10 kg) is associated with a decrease in 
blood pressure,16 18 and reducing body mass index by 1-3 
kg/m2 is associated with a 2-13% lower risk of cardiovas-
cular disease events.19  Similarly, preventing even small 
amounts of weight gain could have an important public 
health impact: gaining 10 lbs (4.5 kg) or more between 
the ages of 40 and 60 increased the risk of developing 
diabetes by 40-70%,17  and a meta-analysis of 221 stud-
ies found a 24-59% increased risk of several cancers.20
Comparison with other studies
In a cohort setting, Hughes et al found that women with 
the highest intake of three flavonoid subclasses, fla-
vones, flavonols, and catechins (a flavan-3-ol), had a 
smaller increase in body mass index over 14 years than 
those with lower intakes.34 These associations were not 
present in men, possibly owing to lower flavonoid 
intake and smaller increases in body mass index over 
time compared with women. In our study population, 
intake of flavonoids was only slightly lower among men 
than in women, and body mass index also increased 
more slowly over time among men; however, we 
detected inverse associations among both men and 
women. Similar to Hughes et al, however, we saw the 
strongest inverse associations among younger women 
(NHS II).
To date, human weight loss trials have examined only 
supplements containing flavan-3-ols and many have 
been too short to test meaningful differences in weight 
loss.35 36  Among 80 overweight people with diabetes, no 
difference was found in weight between the groups ran-
domized to decaffeinated green tea (856 mg/d epigallo-
catechin gallate) versus placebo for one year.37  On the 
other hand, weight and subcutaneous fat decreased 
among 102 overweight/obese people taking 8 g/d oolong 
tea for six weeks, but there was no placebo comparison 
group in this study.36 Often, flavan-3-ol interventions are 
combined with other interventions such as physical 
activity, caffeine, or insulin, and their effects are hard to 
tease apart. Comparing results from trials that run for 
much shorter time periods or use supplements instead 
of whole foods is also difficult because long term higher 
intake of specific fruits and vegetables is generally most 
relevant to public health interventions.
strengths and limitations of study
Our study has some limitations. Although our validated 
food frequency questionnaire specifies portion size, 
measurement error will be present with any assessment t
ab
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6
of diet and the flavonoid content of foods varies 
depending on ripeness, storage conditions, food pro-
cessing, and season, which may introduce additional 
measurement error. As dietary thearubigin intakes are 
crudely measured, we did further analysis excluding 
thearubigins from the flavonoid polymer subclass and 
found a stronger inverse association with weight 
change (−0.61 lbs per increased daily SD over four years 
versus −0.18 lbs).
Furthermore, our food frequency questionnaire did 
not capture all food sources of flavonoids, but it did 
capture the main sources present in the habitual diet. 
Our results could underestimate true associations if 
people who gained weight in the beginning of a four 
year period modified their diet in response and began to 
eat more fruits and vegetables, and hence more flavo-
noids, in order to lose weight (reverse causality). On the 
other hand, our results could overestimate true associ-
ations if people who gained weight stopped eating 
fruits and vegetables. In addition, although we incorpo-
rated a comprehensive list of confounders, residual 
confounding is possible owing to imperfect measure-
ment of confounders and potential unmeasured/
unknown confounders. The source of confounding 
most difficult to control is other constituents of the 
foods that are high in flavonoids; in our analysis, con-
trol for fiber intake substantially attenuated the 
observed associations, except for associations with 
anthocyanins and flavonoid polymers. Finally, our 
results may be generalizable only to people of similar 
age, race, and socioeconomic status.
Strengths of our study include the measurement of 
all major flavonoid subclasses, the inclusions of more 
than 100 000 men and women, a wide age range, and 
up to 24 years of follow-up. Furthermore, each 
 participant completed a validated, semiquantitative 
food frequency questionnaire up to seven times during 
follow-up. We additionally had data on a comprehen-
sive set of potential dietary and lifestyle confounders; 
this and the restriction of this population to partici-
pants with higher education and income reduced resid-
ual confounding due to socioeconomic status. Finally, 
our results were consistent across both sexes and differ-
ent ages.
Conclusions and policy implications
These data may help to refine previous dietary recom-
mendations for the prevention of obesity and its poten-
tial consequences. Our results suggest that choosing 
high flavonoid fruits and vegetables, such as apples, 
pears, berries, and peppers, may help with weight con-
trol. Most Americans consume less than one cup (less 
than two servings) of fruits and less than two cups of 
vegetables daily,38  and juice and potatoes are major 
contributors to intake.38  Beyond increasing intake to 
current recommendations of two cups of fruit and 2.5 
cups of vegetables per day,39 people may be able to max-
imize their health benefit by including optimal fruits 
and vegetables in their daily diets.
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